Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Reliability of the current newborn screening action value for beta thalassaemia disease detection in England: A prospective study.

Daniel Y, Henthorn J.

J Med Screen. 2019 Jun;26(2):67-70. doi: 10.1177/0969141318797373. Epub 2018 Sep 24.

PMID:
30249157
2.
3.

Newborn bloodspot results: predictive value of screen positive test for thalassaemia major.

Streetly A, Latinovic R, Henthorn J, Daniel Y, Dormandy E, Darbyshire P, Mantio D, Fraser L, Farrar L, Will A, Tetlow L.

J Med Screen. 2013 Dec;20(4):183-7. doi: 10.1177/0969141313514217. Epub 2013 Nov 25.

PMID:
24277229
4.

Pathology Harmony moves on: progress on implementation in haematology.

De la Salle B; Pathology Harmony Haematology Sub-Group.

Br J Haematol. 2012 Sep;158(6):804-5. doi: 10.1111/j.1365-2141.2012.09229.x. Epub 2012 Jul 23. No abstract available.

PMID:
22816798
5.

Positive screening and carrier results for the England-wide universal newborn sickle cell screening programme by ethnicity and area for 2005-07.

Streetly A, Latinovic R, Henthorn J.

J Clin Pathol. 2010 Jul;63(7):626-9. doi: 10.1136/jcp.2010.077560.

6.

Implementation of the newborn screening programme for sickle cell disease in England: results for 2003-2005.

Streetly A, Clarke M, Downing M, Farrar L, Foo Y, Hall K, Kemp H, Newbold J, Walsh P, Yates J, Henthorn J.

J Med Screen. 2008;15(1):9-13. doi: 10.1258/jms.2008.007063.

PMID:
18416948
7.

Hb Niigata [beta1(NA1)Val-->Leu] in a Romanian individual resulting from another nucleotide substitution than that found in the Japanese.

Moradkhani K, Henthorn J, Riou J, Phelan L, Préhu C, Wajcman H.

Hemoglobin. 2007;31(4):477-82.

PMID:
17994382
8.

Neonatal screening for sickle cell disorders.

Henthorn JS, Almeida AM, Davies SC.

Br J Haematol. 2004 Feb;124(3):259-63. Review. No abstract available.

PMID:
14717772

Supplemental Content

Loading ...
Support Center